Business Description
aap Implantate AG
ISIN : DE000A3H2101
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.36 | |||||
Equity-to-Asset | 0.64 | |||||
Debt-to-Equity | 0.27 | |||||
Debt-to-EBITDA | -1.36 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -0.61 | |||||
Beneish M-Score | -3.16 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -19.8 | |||||
3-Year EBITDA Growth Rate | 35.6 | |||||
3-Year EPS without NRI Growth Rate | 37.6 | |||||
3-Year FCF Growth Rate | 29.6 | |||||
3-Year Book Growth Rate | -25.8 | |||||
Future 3-5Y Total Revenue Growth Rate | 13.72 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 50.05 | |||||
9-Day RSI | 40.49 | |||||
14-Day RSI | 38.16 | |||||
6-1 Month Momentum % | 68.33 | |||||
12-1 Month Momentum % | 155.7 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.12 | |||||
Quick Ratio | 1.03 | |||||
Cash Ratio | 0.28 | |||||
Days Inventory | 923.89 | |||||
Days Sales Outstanding | 70.22 | |||||
Days Payable | 331.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -37.1 | |||||
Shareholder Yield % | -11.54 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 81.45 | |||||
Operating Margin % | -34.06 | |||||
Net Margin % | -33.34 | |||||
FCF Margin % | -22.81 | |||||
ROE % | -32.25 | |||||
ROA % | -20.14 | |||||
ROIC % | -25.17 | |||||
ROC (Joel Greenblatt) % | -37.7 | |||||
ROCE % | -26.06 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.07 | |||||
PB Ratio | 1.26 | |||||
Price-to-Tangible-Book | 1.49 | |||||
EV-to-EBIT | -5.28 | |||||
EV-to-EBITDA | -8.59 | |||||
EV-to-Revenue | 1.74 | |||||
EV-to-FCF | -7.65 | |||||
Price-to-Median-PS-Value | 0.39 | |||||
Price-to-Net-Current-Asset-Value | 7.47 | |||||
Earnings Yield (Greenblatt) % | -18.94 | |||||
FCF Yield % | -15.82 | |||||
Forward Rate of Return (Yacktman) % | -8.47 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
aap Implantate AG Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 12.06 | ||
EPS (TTM) (€) | -0.49 | ||
Beta | 0.6 | ||
Volatility % | 83.76 | ||
14-Day RSI | 38.16 | ||
14-Day ATR (€) | 0.106701 | ||
20-Day SMA (€) | 1.643 | ||
12-1 Month Momentum % | 155.7 | ||
52-Week Range (€) | 0.7 - 2.98 | ||
Shares Outstanding (Mil) | 12.08 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
aap Implantate AG Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
aap Implantate AG Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
aap Implantate AG Frequently Asked Questions
What is aap Implantate AG(XTER:AAQ1)'s stock price today?
When is next earnings date of aap Implantate AG(XTER:AAQ1)?
Does aap Implantate AG(XTER:AAQ1) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |